Table 1 Characteristics of the 106 children diagnosed with COVID-19 who underwent chest radiography
From: Radiographic patterns and severity scoring of COVID-19 pneumonia in children: a retrospective study
Characteristics | All (N = 106) | Asymptomatic (n = 44) | Symptomatic (n = 62) | p-value |
|---|---|---|---|---|
Sex | 0.425 | |||
Male, n (%) | 59 (55.7%) | 27 (61.4%) | 32 (51.6%) | |
Female, n (%) | 47 (44.3%) | 17 (38.6%) | 30 (48.4%) | |
Age, median [IQR] | 6 [4, 12] | 5 [3, 8] | 8 [4, 14] | 0.006* |
Age group, n (%) | 0.022* | |||
0– < 5 years | 40 (37.7%) | 22 (50%) | 18 (29%) | |
5– < 9 years | 29 (27.4%) | 13 (29.5%) | 16 (25.8%) | |
9–18 years | 37 (34.9%) | 9 (20.5%) | 28 (45.2%) | |
Age < 1 year | 7 (6.6%) | 3 (6.8%) | 4 (6.5%) | 1.000 |
Cycle threshold of RT-PCR SARS- | ||||
CoV-2 (n = 22)a | ||||
ORF-gene, mean (SD) | 22.6 (6.1) | 22.1 (5.3) | 23.2 (7) | 0.682 |
N-gene, mean (SD) | 21.1 (5.9) | 20.5 (6.6) | 21.8 (5.3) | 0.619 |
Treatment | ||||
Required oxygen support, n (%) | 5 (4.7%) | 2 (4.5%) | 3 (4.8%) | 1.000 |
Favipiravir, n (%) | 34 (32.1%) | 7 (15.9%) | 27 (43.5%) | 0.005* |
Remdesivir, n (%) | 9 (8.5%) | 4 (9.1%) | 5 (8.1%) | 1.000 |
Antibiotic, n (%) | 9 (8.5%) | 4 (9.1%) | 5 (8.1%) | 1.000 |
Steroid, n (%) | 10 (9.4%) | 4 (9.1%) | 6 (9.7%) | 1.000 |
CXR results | 0.647 | |||
Abnormal initial CXR findings, n (%) | 101 (95.3%) | 41 (93.2%) | 60 (96.8%) | |
Normal initial CXR findings, n (%) | 5 (4.7%) | 3 (6.8%) | 2 (3.2%) | |
Severity score of abnormal CXR | 0.737 | |||
Images | ||||
Mild (score, 1–2), n (%) | 81 (76.4%) | 32 (72.7%) | 49 (79%) | |
Moderate (score, 3–4), n (%) | 21 (19.8%) | 10 (22.7%) | 11 (17.7%) | |
Severe (score, 5–6), n (%) | 4 (3.8%) | 2 (4.6%) | 2 (3.3%) | |